These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1011 related items for PubMed ID: 10741751
1. TabBO: a model reflecting common molecular features of androgen-independent prostate cancer. Navone NM, Rodriquez-Vargas MC, Benedict WF, Troncoso P, McDonnell TJ, Zhou JH, Luthra R, Logothetis CJ. Clin Cancer Res; 2000 Mar; 6(3):1190-7. PubMed ID: 10741751 [Abstract] [Full Text] [Related]
2. The association of p21((WAF-1/CIP1)) with progression to androgen-independent prostate cancer. Fizazi K, Martinez LA, Sikes CR, Johnston DA, Stephens LC, McDonnell TJ, Logothetis CJ, Trapman J, Pisters LL, Ordoñez NG, Troncoso P, Navone NM. Clin Cancer Res; 2002 Mar; 8(3):775-81. PubMed ID: 11895908 [Abstract] [Full Text] [Related]
3. Extended survivability of prostate cancer cells in the absence of trophic factors: increased proliferation, evasion of apoptosis, and the role of apoptosis proteins. Tang DG, Li L, Chopra DP, Porter AT. Cancer Res; 1998 Aug 01; 58(15):3466-79. PubMed ID: 9699682 [Abstract] [Full Text] [Related]
4. Establishment of two human prostate cancer cell lines derived from a single bone metastasis. Navone NM, Olive M, Ozen M, Davis R, Troncoso P, Tu SM, Johnston D, Pollack A, Pathak S, von Eschenbach AC, Logothetis CJ. Clin Cancer Res; 1997 Dec 01; 3(12 Pt 1):2493-500. PubMed ID: 9815652 [Abstract] [Full Text] [Related]
5. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. Fizazi K, Yang J, Peleg S, Sikes CR, Kreimann EL, Daliani D, Olive M, Raymond KA, Janus TJ, Logothetis CJ, Karsenty G, Navone NM. Clin Cancer Res; 2003 Jul 01; 9(7):2587-97. PubMed ID: 12855635 [Abstract] [Full Text] [Related]
6. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells. Drew L, Fine RL, Do TN, Douglas GP, Petrylak DP. Clin Cancer Res; 2002 Dec 01; 8(12):3922-32. PubMed ID: 12473608 [Abstract] [Full Text] [Related]
7. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway. Yang J, Fizazi K, Peleg S, Sikes CR, Raymond AK, Jamal N, Hu M, Olive M, Martinez LA, Wood CG, Logothetis CJ, Karsenty G, Navone NM. Cancer Res; 2001 Jul 15; 61(14):5652-9. PubMed ID: 11454720 [Abstract] [Full Text] [Related]
8. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline. Hara T, Nakamura K, Araki H, Kusaka M, Yamaoka M. Cancer Res; 2003 Sep 01; 63(17):5622-8. PubMed ID: 14500404 [Abstract] [Full Text] [Related]
9. Expression of cell-cycle mediators in ovarian cancer cells after transfection with p16(INK4a), p21(WAF1/Cip-1), and p53. Ramirez PT, Gershenson DM, Tortolero-Luna G, Ramondetta LM, Fightmaster D, Wharton JT, Wolf JK. Gynecol Oncol; 2001 Dec 01; 83(3):543-8. PubMed ID: 11733969 [Abstract] [Full Text] [Related]
10. Regulation of Bcl-2 during androgen-unresponsive progression of prostate cancer. Rothermund CA, Kondrikov D, Lin MF, Vishwanatha JK. Prostate Cancer Prostatic Dis; 2002 Dec 01; 5(3):236-45. PubMed ID: 12496988 [Abstract] [Full Text] [Related]
11. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Perego P, Giarola M, Righetti SC, Supino R, Caserini C, Delia D, Pierotti MA, Miyashita T, Reed JC, Zunino F. Cancer Res; 1996 Feb 01; 56(3):556-62. PubMed ID: 8564971 [Abstract] [Full Text] [Related]
12. Development and validation of sensitive assays to quantitate gene expression after p53 gene therapy and paclitaxel chemotherapy using in vivo dosing in tumor xenograft models. Wen SF, Xie L, McDonald M, DiGiacomo R, Chang A, Gurnani M, Shi B, Liu S, Indelicato SR, Hutchins B, Nielsen LL. Cancer Gene Ther; 2000 Nov 01; 7(11):1469-80. PubMed ID: 11129289 [Abstract] [Full Text] [Related]
13. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, Buttyan R. Cancer Res; 1995 Oct 01; 55(19):4438-45. PubMed ID: 7671257 [Abstract] [Full Text] [Related]
14. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells. Lowe SL, Rubinchik S, Honda T, McDonnell TJ, Dong JY, Norris JS. Gene Ther; 2001 Sep 01; 8(18):1363-71. PubMed ID: 11571575 [Abstract] [Full Text] [Related]
15. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Gupta S, Afaq F, Mukhtar H. Oncogene; 2002 May 23; 21(23):3727-38. PubMed ID: 12032841 [Abstract] [Full Text] [Related]
16. Combination E2F-1 and p53 gene transfer does not enhance growth inhibition in human squamous cell carcinoma of the head and neck. Frank DK, Liu TJ, Frederick MJ, Clayman GL. Clin Cancer Res; 1998 Sep 23; 4(9):2265-72. PubMed ID: 9748148 [Abstract] [Full Text] [Related]
17. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression. Sun A, Tang J, Hong Y, Song J, Terranova PF, Thrasher JB, Svojanovsky S, Wang HG, Li B. Prostate; 2008 Mar 01; 68(4):453-61. PubMed ID: 18196538 [Abstract] [Full Text] [Related]
18. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis. Aranha O, Grignon R, Fernandes N, McDonnell TJ, Wood DP, Sarkar FH. Int J Oncol; 2003 Apr 01; 22(4):787-94. PubMed ID: 12632069 [Abstract] [Full Text] [Related]
19. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis. Hemmati PG, Gillissen B, von Haefen C, Wendt J, Stärck L, Güner D, Dörken B, Daniel PT. Oncogene; 2002 May 09; 21(20):3149-61. PubMed ID: 12082630 [Abstract] [Full Text] [Related]
20. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells. Srivastava P, Russo J, Mgbonyebi OP, Russo IH. Anticancer Res; 1998 May 09; 18(6A):4003-10. PubMed ID: 9891438 [Abstract] [Full Text] [Related] Page: [Next] [New Search]